Earnings Orion Engineered Carbons Confronts Cycle Lows With Cost Reset and Disciplined 2026 Outlook 2 weeks ago Orion Engineered Carbons S.A. (NYSE: OEC) is a Luxembourg-based global supplier of specialty and rubber carbon black serving tire, coatings,… MITT Solidifies Market Position with Arc Home Expansion and Disciplined Securitization 2 weeks ago TPG Mortgage Investment Trust, Inc. (NYSE: MITT), with a market capitalization of approximately $0.29 billion, is a residential mortgage real estate… Energy Transfer LP Announces Record Full-Year 2025 Results and Increased 2026 Guidance 2 weeks ago Energy Transfer LP (NYSE: ET) today reported financial and operational results for the fourth quarter and fiscal year ended December… DFIN’s Software Pivot Pays Off: High Margins and Recurring Revenue Lead the Way 2 weeks ago Donnelley Financial Solutions Inc (NYSE: DFIN), a provider of regulatory compliance, financial technology, and risk management solutions, had a market… Cardiovascular and Robotics Drive Medtronic’s Record 10-Quarter Revenue Spike 2 weeks ago Medtronic PLC (NYSE: MDT) is a Dublin-based global medical technology company with a market capitalization of approximately $110 billion. The… CNH Industrial Beats Q4 Estimates but Braces for 2026 Industry Trough 2 weeks ago CNH Industrial NV (NYSE: CNH) reported fourth-quarter 2025 financial results on Tuesday that exceeded Wall Street expectations, driven by strong… Tower Semiconductor Q4 2025 Drives Record Revenue and Aggressive CapEx Expansion 2 weeks ago Tower Semiconductor (NASDAQ: TSEM, TASE: TSEM) delivered a standout performance for the fourth quarter ended December 31, 2025, reporting record… NeoGenomics Full Year 2025 Revenue Rises to $727 Million 2 weeks ago NeoGenomics, Inc. (Nasdaq: NEO) shares declined 5.27% in Tuesday’s trading session following the release of its fourth quarter and full… Krystal Biotech Surpasses Expectations as VYJUVEK Drives Record 2025 Revenue and International Expansion 2 weeks ago Krystal Biotech, Inc. (NASDAQ: KRYS), a leader in redosable gene therapies, today announced record-breaking financial results for the fourth quarter… Ceragon Full year 2025 Revenue Totals $338.7 million 2 weeks ago Ceragon Networks Ltd. (Nasdaq: CRNT) shares declined 7.30% in Tuesday’s trading session following the release of its fourth-quarter and full-year… Next» « Previous